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[65] 
California Cannabis Regulations and the Federal 
Food, Drug & Cosmetic Act: A Product Liability 
Perspective of Edible Cannabis 
Alexis Lazzeri* 
 
The country’s relationship with marijuana is changing,  
slowly, and one person’s pusher is another’s caregiver. 
- Chief Judge Scott W. Dales1 
 
INTRODUCTION 
 
From the passage of Proposition 215 to present day, California’s 
cannabis industry has transformed from access solely for medical patients to 
a nearly three billion dollar a year industry with legal medicinal and adult-
use consumption.2 With this rise in accessibility, edible cannabis products 
are being consumed more than ever.3 “Edibles” are food and drink products 
infused with cannabis, a mix of THC (i.e., delta 9 - tetrahydrocannabinol) 
and CBD (i.e., cannabidiol)—with varying levels of each, depending on the 
desired effect.4 CBD is a nonintoxicating compound often used to treat 
physical ailments and chronic conditions, while THC delivers a euphoric 
high.5 Edibles appeal to a consumer market that does not want to smoke to 
 
          * J.D. Candidate, University of California, Hastings College of the Law, 2020; B.A. History, 
University of California, Berkeley, 2013. 
 1. In re Johnson, 532 B.R. 53, 54 (Bankr.W.D.Mich. 2015). 
 2. Thomas Fuller, Now for the Hard Part: Getting Californians to Buy Legal Weed, N.Y. TIMES 
(Jan. 2, 2019), https://www.nytimes.com/2019/01/02/us/buying-legal-weed-in-california.html (citing 
that the $2.5 billion of legal cannabis sold in California in 2018 is half a billion dollars less than in 2017, 
when only medical marijuana was legal. California continues to have a robust black market—CFDA 
report showed the state produces as much as 15.5 million pounds a year and is consuming only 2.5 million 
pounds; most of this surplus is leaching out across the country illegally); Janissa Delzo, California Could 
Make More Money From Legal Pot Than Beer by 2019, NEWSWEEK (Dec. 30, 2017), https://www.news 
week.com/california-money-legal-pot-beer-766698. 
 3. Mike Montgomery, Edibles are the Next Big Thing for Pot Entrepreneurs, FORBES (July 19, 
2017), https://www.forbes.com/sites/mikemontgomery/2017/07/19/edibles-are-the-next-big-thing-for-
pot-entrepreneurs/#2307fcfd576b. 
 4. John Campbell & Sahib Singh, Budding Torts: Forecasting Emerging Tort Liability in the 
Cannabis Industry, 30 LOY. CONSUMER L. REV. 338, 345 (2018). 
 5. CBD vs. THC: What’s the Difference?, LEAFLY (July 3, 2018), https://www.leafly.com/new 
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get high (increasingly, senior citizens), and can “account for 25 to 60 percent 
of a dispensary’s profits.”6 In 2016 alone, Californian’s consumed more than 
$180 million in cannabis-infused edibles.7 The edible market is competitive, 
having transformed from melted-down, mass-produced chocolate (where 
taste was an afterthought) to handmade chocolate bars with Tahitian vanilla 
beans.8 
California has promulgated a complex regulatory scheme for cannabis 
entrepreneurs.9 Governor Gavin Newsom estimates it will “take at least five 
years to fully develop.”10 “Fragmented and uncoordinated” enforcement 
allows California’s black market to flourish.11 As of September 2019, 887 
pot retailers were licensed in the state, yet “as much as 80% of the marijuana 
sold in California [continues to] come from the black market.”12 This 
disparity creates unfair competition for licensed businesses, as well a public 
safety hazard—areas where both regulation and enforcement are crucial.13 
Despite this, under federal law possession, cultivation and the sale of 
marijuana remains illegal.14 Federally criminalized cannabis leaves 
 
s/cannabis-101/whats-the-deal-with-these-high-cbd-strains/print/. 
 6. Senior citizens are increasingly turning away from opioids and turning to cannabis to treat 
various aches, and sleeplessness. Professor of Psychiatry and Aging at UCLA, Dr. Gary Small, espoused 
that adults 65 and over are the fastest-growing segment of the marijuana-using population, and the side 
effects of cannabis can be quite serious for seniors—dizziness can lead to falling and impaired memory 
if dosage is “incorrect.” This usage by seniors should be considered when considering product liability 
issues. John Rogers, Bingo and Bongs: More Seniors Seek Pot for Age-Related Aches, WASH. POST (Mar. 
25, 2019), https://www.washingtonpost.com/business/bingo-and-bongs-more-seniors-seek-pot-for-age-
related-aches/2019/03/25/98869586-4eb3-11e9-bdb7-44f948cc0605story.html?noredirect=on&utm_t 
erm=.27f518468ad9; see also Montgomery, supra note 3. 
 7. Montgomery, supra note 3. 
 8. Id. 
 9. CAL. BUS. & PROF. CODE §§ 26000 – 26134 (2019); State Licensing Authorities, CALIFORNIA 
CANNABIS PORTAL, https://cannabis.ca.gov/state-licensing-authorities/ (last visited Oct. 19, 2019). 
 10. Patrick McGreevy, California’s Black Market for Pot is Stifling Legal Sales. Now the Governor 
Wants to Step up Enforcement, L.A. TIMES (Feb. 18, 2019), https://www.latimes.com/politics/la-pol-ca-
gavin-newsom-crackdown-pot-black-market-20190219-story.html?sfns=mo. 
 11.  Id. 
 12. Bureau of Cannabis Control – License Search, CALIFORNIA CANNABIS PORTAL, https://canna 
bis.ca.gov/licensed-cannabis-businesses/, (last visited Oct. 19, 2019) (noting that retailers includes both 
storefront and non-storefront retailers); McGreevy, supra note 10 (“According to an estimate by New 
Frontier Data, a firm that tracks cannabis sales and trends”); Thomas Fuller, Getting Worse, Not Better’: 
Illegal Pot Market Booming in California Despite Legalization, N.Y. TIMES (Apr. 27, 2019), https:// 
www.nytimes.com/2019/04/27/us/marijuana-california-legalization.html. 
13. McGreevy, supra note 10 (“According to an estimate by New Frontier Data, a firm that tracks 
cannabis sales and trends”); Fuller, supra note 2; Andrew Bowen, Chief of California’s Bureau of 
Cannabis Control is ‘Really, Really Busy’, KPBS (July 25, 2018), https://www.kpbs.org/news/2018/ 
jul/25/bureau-cannabis-control-lori-ajax-marijuana-legal/. 
 14. CONTROLLED SUBSTANCES ACT, 21 U.S.C. § 812(b)(1); CONTROLLED SUBSTANCES ACT 21 
U.S.C. § 812 – Schedule I (c)(17). 
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California’s edible industry devoid of any civil federal regulation.15 This 
lapse, in conjunction with California’s regulatory scheme, poses particularly 
unique challenges to edible companies that are trying to stay in compliance 
with the law, avoid lawsuits, and enforcement actions.16 As one might 
surmise, this rise in consumption is troublesome for cannabis manufacturers 
and a potential boon for product liability attorneys.17 Edibles are unique, and 
face product liability exposure as both a food, and as an intoxicating 
substance, typically “arising from design defects, specific language in 
advertising and inadequate warnings.”18 
This Note illuminates how even in the current regulated California 
environment, edible cannabis products can pose a serious risk to consumers 
if not properly made, labeled, and consumed, which may subsequently 
increase demand for product liability attorneys in the very near future. As a 
foundation for understanding, Part One of this Note provides a brief 
historical background on cannabis laws in California, the current regulatory 
scheme under the Medicinal and Adult-Use Cannabis Regulation and Safety 
Act (“MAUCRSA”) and explores continued federal prohibition of cannabis 
issues. If cannabis were not a controlled substance under the Controlled 
Substances Act (“CSA”) and was regulated by the U.S. Food & Drug 
Administration (“FDA”) under the Food, Drug Cosmetic Act of 1938 
(“FDCA”), cannabis could be regulated as a food additive or as a new dietary 
ingredient. Consideration of what that would look like is relevant here. Part 
Two of this Note will discuss the relevant California regulatory requirements 
for edible products under the Bureau of Cannabis Control and California 
Department of Public Health, and what that regulation might look like under 
the FDA. 
Part Three of this Note lays out the impact of product liability issues 
facing current edible cannabis manufacturers, distributors, and retailers. This 
Note will consider manufacturing defects, design defects, and failure to warn 
issues for edible cannabis products that comply with the FDCA and 
California regulations in tandem, and those that do not comply with the 
FDCA, but do comply with California regulations. This analysis shows how 
current regulations in California are still slightly inadequate for the industry 
and for consumers. As such, all cannabis companies should incorporate a 
policy of over-compliance. This policy will require cannabis companies to 
 
 15. Michelle L. Burton & Robert S. May, New Era of Liability: Comparative Analysis of Regulation 
of Marijuana and Other Controlled Substances, 60 No. 9 DRI for Def. 26, 6 (Sept. 2018). 
 16. Daniel G. Barrus, Tasty THC: Promises and Challenges of Cannabis Edibles, METHODS REP 
RTI PRESS 6 (Nov. 2016), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260817/pdf/nihms-8302 
25.pdf. 
17.  Montgomery, supra note 3. 
 18. Burton & May, supra note 15. 
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implement additional recall procedures, ensure proper consumer notification 
of intended side effects, and the dangers of overconsumption at the time of 
sale. Most importantly, a national standard for edibles must be set at 10mg 
and widely publicized. Lastly, this Note considers the possibility of 
implementing gram shop laws and liability immunity under California Civil 
Code section 1714.45. 
 
1. CALIFORNIA’S TWO DECADE FIGHT FOR LEGALIZATION 
AND REGULATION OF ADULT-USE CANNABIS 
 
1.1 HISTORICAL BACKGROUND ON PROP. 215 AND CALIFORNIA’S 
MEDICAL MARIJUANA 
 
Proposition 215 (“Prop. 215”), commonly known as the Compassionate 
Use Act (“CUA”), passed in California on November 1996 with 56% of the 
vote.19 Prop. 215 exempted a seriously ill patient, or their primary caregiver, 
from state prosecution for possession and cultivation of marijuana, so long 
as their physician recommended the use of cannabis for medical treatment.20 
In short, Californians decided that “criminalizing sick people who smoked 
pot was bad public policy.”21 However, Prop. 215 did not specifically 
address how patients could legally obtain their medically-recommended 
marijuana nor did it set age limits on consumption, or even spell out how 
someone could legally sell the herb.22 The proposition was novel because it, 
technically, did not legalize cannabis, “it simply created a doctor-
recommended exception to state enforcement.”23 Prop. 215’s careful 
wording allowed it to circumvent the federal CSA, which does not speak to 
recommending the therapeutic use of cannabis.24 However, those opposed to 
the legalization aimed to roll back the CUA by “utiliz[ing] the courts to put 
on show trials, send the innocent to prison, deny medication to the seriously 
ill, and terrorize America’s weakest citizens with fascistic paramilitary raids 
that ransacked their homes and property.”25 Thus, California’s gray market 
 
 19. U.S. v. Cannabis Cultivators Club, 5 F. Supp. 2d 1086, 1091 (N.D.Cal. 1998); see also CAL. 
HEALTH & SAFTEY CODE § 11362.5 (West 2019). 
 20. CAL. HEALTH & SAFTEY CODE § 11357 (West 2019); CAL. HEALTH & SAFTEY CODE § 11362.5 
(West 2019); see also Cannabis Cultivators Club, 5 F. Supp. at 1091; CAL. HEALTH & SAFTEY CODE § 
11358 (West 2019). 
 21. MARTIN A. LEE, SMOKE SIGNALS: A SOCIAL HISTORY OF MARIJUANA – MEDICAL, 
RECREATIONAL, AND SCIENTIFIC 247 (Scribner 2012). 
 22.  Id. at 240. 
 23. Id. 
 24. Id. at 251. 
 25.  Id. at 249. 
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was largely run by people willing to put their name on the line for people 
with illnesses and in recovery.26 This collective movement created 
complicated precedent, and dispensaries operated at the whim of the DEA 
and local law enforcement, knowing that they could be “busted at a 
moment’s notice.”27 Following the enactment of the CUA, there was no 
substantive regulation of the edible cannabis products available to medicinal 
cannabis users in California for the next 20 years. 
 
1.2 MAUCRSA AND CURRENT REGULATORY BODIES IN CALIFORNIA: 
BCC, CDPH, CDFA 
 
On November 8, 2016, 20 years after the passage of Prop. 215 
California legalized adult-use of cannabis with Proposition 64, also known 
as the Adult Use of Marijuana Act (“AUMA”).28 AUMA allowed adults, 21 
years of age or older, to legally grow, possess, and use cannabis for non-
medicinal purposes, with few restrictions.29 AUMA also legalized the sale 
and distribution of marijuana through a regulated business as of January 1, 
2018.30 To consolidate the governance of adult-use and medical marijuana, 
the California State Legislature passed Senate Bill 94 in 2017, creating the 
Medicinal and Adult-Use Cannabis Regulation and Safety Act 
(“MAUCRSA”).31  
Following the passage of AUMA, three state agencies were charged 
with cannabis licensing authority: the Bureau of Cannabis Control (“BCC”), 
the California Department of Food and Agriculture (“CDFA”), and the 
 
 26.  Id. at 255.  
 27. Marijuana collectives were established to grow and provide cannabis as a compassionate care 
non-profit. Some collectives would donate the flower to low-income, terminally ill patients. Due to the 
legalization of cannabis (and thus, taxation) collectives simply could not sustain themselves legally, 
unless licensed, or financially. See generally U.S. v. Cannabis Cultivators Club, 5 F. Supp. 2d 1086 (N.D. 
Cal. 1998); U.S. v. Rosenthal, No. 03-10370, D.C. No. CR-02-00053-3-CRB (9th Cir. 2006); City of 
Corona v. Naulls, 166 Cal.App.4th 418 (2008); People v. Baniani, 229 Cal. App. 4th 45 (2014); Mary 
Carreon, California’s New Cannabis Laws Squeeze Out Compassionate Care Programs, FORBES (Jan. 
28, 2019), https://www.forbes.com/sites/marycarreon/2018/01/29/californias-new-cannabis-laws-push-
out-compassionate-care-programs/#5eb5abbb25fd; John Schroyer, End of an Era: After Jan. 9, Cannabis 
Unlicensed Medical Cannabis Collectives/Co-ops Illegal, MARIJUANA BUSINESS DAILY (Jan. 3, 2019), 
https://mjbizdaily.com/california-unlicensed-medical-marijuana-collectives-illegal-jan-9/; LEE, supra 
note 21. 
 28. Thomas Fuller, Californians Legalize Marijuana in Vote That Could Echo Nationally, N.Y. 
TIMES (Nov. 9, 2016), https://www.nytimes.com/2016/11/09/us/politics/marijuana-legalization.html; 
CAL. HEALTH & SAFETY CODE §§ 11362.1 – 11362.3 (West 2019). 
 29. About Us, CALIFORNIA CANNABIS PORTAL, https://cannabis.ca.gov/about_us/ (last visited Oct. 
26, 2019); CAL. HEALTH &SAFETY CODE §§ 11362.1 – 11362.3 (West 2019). 
 30. Id.; CAL. HEALTH & SAFETY CODE § 11362.3 (West 2019). 
 31. MAUCRSA melded MCRSA, California’s medical-only regulations passed by the legislature, 
and the AUMA. CALIFORNIA CANNABIS PORTAL, supra note 29. 
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California Department of Public Health (“CDPH”).32 The BCC is the 
principal regulatory agency for California commercial cannabis; it is 
responsible for licensing retailers, distributors, testing laboratories, 
microbusinesses, and temporary cannabis events.33 The CDFA is charged 
with licensing and regulating commercial cannabis cultivators.34 Lastly, the 
CDPH is in authority of the regulation of all commercial cannabis 
manufacturing.35 Legalization of cannabis brought an end to over two 
decades of zero edible cannabis product regulation. Consequently, 
California’s loosely regulated system of medical cannabis collectives 
became illegal on January 9, 2019.36 On January 16, 2019, the Office of 
Administrative Law officially approved state cannabis regulations for the 
BCC, CDPH, and CDFA, which became effective immediately.37 
 
1.3 FEDERAL PROHIBITION REMAINS PROBLEMATIC – POSSIBLE 
REGULATION UNDER FDA & FDCA 
 
Sixty five percent of Americans believe that marijuana should be 
legalized, double what it was nearly 20 years ago.38 Today, adult-use 
cannabis is legal in 11 states, including D.C., and medicinal cannabis is legal 
in 33.39 Given this nationwide shift, cannabis will very likely become 
federally decriminalized within a decade.40 For now, however, the CSA 
 
 32. State Licensing Authorities, CALIFORNIA CANNABIS PORTAL, https://cannabis.ca.gov/state-
licensing-authorities/ (last visited Oct. 19, 2019). 
 33. Id. 
 34. Id. (explaining that CalCannabis is split into three branches: Licensing, Compliance and 
Enforcement, and Administration, and establishes and manages California’s track-and-trace system). 
 35. Id. (stating that the CDPH’s mission is to “protect public health and safety by ensuring 
commercial cannabis manufacturers operate safe, sanitary workplaces and follow good manufacturing 
practices to produce products that are free of contaminants, meet product guidelines and are properly 
packaged and labeled”). 
36.  Fuller, supra note 2. 
 37. U.S. v. Pisarski, 274 F.Supp.3d 1032 (2017) (enjoining criminal prosecution for those who could 
establish full compliance with California law); see also, New Cannabis Regulations Approved by the 
Office of Administrative Law, CALIFORNIA CANNABIS PORTAL (Jan. 16, 2019), https://cannabis.ca.gov/ 
2019/01/16/new-cannabis-regulations-approved-by-the-office-of-administrative-law/. 
 38. Brandi Kellam, Legalizing Marijuana? Americans Support it, But Not Enough to Sway Their 
Vote in 2020, CBS NEWS (Apr. 23, 2019), https://www.cbsnews.com/news/legalizing-marijuana-ameri 
cans-support-it-but-not-enough-to-sway-their-vote-in-2020/; see also, Hannah Hartig & Abigail Geiger, 
About Six-in-Ten Americans Support Marijuana Legalization, PEW RESEARCH CENTER: FACTTANK (Oct. 
8, 2018), https://www.pewresearch.org/fact-tank/2018/10/08/americans-support-marijuana-legalization/. 
 39. Jiachuan Wu & Daniella Silva, MAP: See the States Where Marijuana is Legal, NBC NEWS 
(Nov. 20, 2018), https://www.nbcnews.com/news/us-news/map-see-if-marijuana-legal-your-state-n938 
426. 
 40. Eric Sandy & Melissa Schiller, Democrats Are Building Their 2020 Presidential Campaigns. 
Where Do They Stand on Cannabis Reform?, CANNABIS BUSINESS TIMES (Apr. 22, 2019), https://www. 
cannabisbusinesstimes.com/article/democrat-contenders-presidential-election-2020-cannabis-policy/. 
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classifies cannabis as a Schedule I drug, designating that there are no 
currently accepted medical uses and a high potential for abuse.41 The FDA 
has sole authority to approve any drug or food for use in the United States.42 
Under the FDCA, it is currently unlawful to introduce food containing added 
CBD or THC into interstate commerce because “both CBD and THC are 
active ingredients in FDA-approved drugs and were the subject of substantial 
clinical investigations before they were marketed as foods or dietary 
supplements.”43 However, the recently passed “Farm Bill of 2018” legalized 
hemp-derived CBD, and a public meeting was held on May 31, 2019 for the 
FDA to begin developing a set of rules for CBD regulation.44 The meeting 
was largely organized for the FDA to collect scientific data and information 
about the marketing, quality, sale, and safety of CBD products on the market 
today.45 The FDA espouses that they are “committed to sound, science-based 
policy on CBD.”46 Despite this, the current patchwork regulatory system 
across the U.S. remains incredibly problematic for the health and safety of 
retailers and consumers. 
Comparatively, there are no such plans for THC to become regulated 
under the FDA, yet there are edibles in the current market in California (and 
many other states) that are labeled and packaged according to specific state 
standards. The Nutritional Labeling and Education Act (“NLEA”) 
enumerates that no state may directly or indirectly establish any requirement 
for the labeling of food that is “not identical to” the federal requirements.47 
“Not identical to” is defined as a state requirement that imposes obligations 
concerning the composition or labeling of food, which are not imposed by 
corresponding federal regulations, or differ from those specifically imposed 
 
 41. CONTROLLED SUBSTANCES ACT, 21 U.S.C § 812(c)(17); see generally Gonzales v. Raich, 545 
U.S. 1 (2005); Drug Scheduling, DEA, https://www.dea.gov/drug-scheduling (last visited Oct. 19, 2019). 
 42. Drugs of Abuse, A DEA Resource Guide: 2017 Edition, U.S. DEPARTMENT OF JUSTICE DRUG 
ENFORCEMENT ADMINISTRATION, 75 (2017), https://www.dea.gov/sites/default/files/drug_of_abuse.pdf. 
 43. New Steps to Advance Agency’s Continued Evaluation of Potential Regulatory Pathways for 
Cannabis-Containing and Cannabis-Derived Products, FDA (2019) (statement of Scott Gottlieb, M.D., 
FDA Commissioner), https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm63.504 
8.htm (noting that CBD is an active ingredient in the FDA-approved Epidiolex, setting a precedent for 
any products containing CBD to require R&D and clinical trials to obtain FDA approval). 
 44. AGRICULTURE IMPROVEMENT ACT OF 2018, H.R. 2, 115th Cong. § 10113 (2018); Gottlieb, 
supra note 43. 
 45. Presentations: FDA’s Scientific Data and Information about Products Containing Cannabis or 
Cannabis-Derived Compounds Public Hearing, FDA (July 3, 2019), https://www.fda.gov/news-events/ 
fda-meetings-conferences-and-workshops/presentations-fdas-scientific-data-and-information-about-
products-containing-cannabis-or-cannabis. 
 46. Amy Abernethy, M.D., Ph.D., & Lowell Schiller, J.D., FDA is Committed to Sound, Science-
based Policy on CBD, FDA (July 17, 2019), https://www.fda.gov/news-events/fda-voices-perspectives-
fda-leadership-and-experts/fda-committed-sound-science-based-policy-cbd. 
 47. U.S. CONST. art. 6, cl. 2; 21 U.S.C.A. § 343-1(a)(5) (West 2019). 
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by or contained within relevant federal regulations.48 The FDCA lays out 
federal packaging and labeling standards for food products.49 However, the 
illegality of edibles under the CSA leaves the California edible industry void 
of any federal civil regulation.50 It is pertinent that cannabis is de-scheduled 
from the CSA for it to be properly regulated by the FDA. Congress’ 
categorization of products as either a food or drug is determined by “the use 
which the product is to be put will determine the category into which it will 
fall.” 51 Therefore, it is likely that THC added to food will be considered a 
food additive or a new dietary ingredient. 
 
1.3.1 Unapproved Food Additive 
 
A food additive is defined as a substance whose intended use is 
reasonably expected to “become a component” or “affect the characteristics 
of any food” not ‘generally recognized as safe’ (“GRAS”).52 The 1958 Food 
Additives Amendment states that “the use of any ‘food additive’. . . renders 
a food adulterated unless the use complies with an FDA food additive 
regulation.”53 A food is adulterated if it contains any food additives that are 
not GRAS, or contains a dietary supplement or ingredient that “presents a 
significant or unreasonable risk of illness or injury under conditions of use 
recommended or suggested in labeling” or “for which there is inadequate 
information to provide reasonable certainty that such ingredient does not 
present a significant or unreasonable risk of illness or injury.”54 This 
‘reasonable certainty’ can be shown “through the presentation of scientific 
evidence,” submitted in a food additive petition to the FDA showing with “a 
reasonable certainty that no harm will result from the proposed use of an 
additive.”55 
A food additive petition must contain “data bearing on the physical or 
other technical effect which the additive is intended to produce.”56 The FDA 
is empowered by statute to attach specific labeling requirements and 
 
 48. 21 C.F.R. § 100.1(c)(4)(i-ii) (West 2019). 
 49. 21 U.S.C.A. § 343 (West 2019). 
 50. Burton & May, supra note 15. 
 51.  Gottlieb, supra note 43; Lewis A. Grossman, Food, Drugs, And Droods: A Historical 
Consideration of Definitions and Categories in American Food and Drug Law, 93 CORNELL L. REV. 
1091, 1116 (2008). 
 52.  21 U.S.C.A § 321(s) (West 2019); see also, CAL. HEALTH & SAFETY CODE § 109940 (West 
2019) (GRAS means generally recognized as safe under the FDA.). 
 53. 21 U.S.C.A § 321(s) (West 2019); Grossman, supra note 51, at 1129. 
 54. 21 U.S.C.A § 321(s) (West 2019); Grossman, supra note 51, at 1129. 
 55. Grossman, supra note 51.  
 56. 21 U.S.C.A. § 348(b)(2)(C) (West 2019). 
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conditions for safe use to any food additive.57 If the additive’s tolerance 
limitation cannot be articulated to ensure “intended physical or technical 
effect,” the FDA will simply not approve it.58 Currently, “under section 
301(ll) of the FD&C Act,” it is illegal to introduce “into interstate commerce 
any food . . . to which has been added a substance which is an active 
ingredient in a drug product that has been approved under section 505 of the 
FD&C Act, or a drug for which substantial clinical investigations have been 
instituted and for which the existence of such investigations has been made 
public.”59 At this time, the FDA has determined that THC does not fit into 
any exceptions to this rule.60 The Amendment’s legislative history articulates 
that proof of a reasonable certainty that no harm would result from use is 
necessary, however, “it does—and cannot—require proof beyond any 
possible doubt that no harm will result under any conceivable 
circumstances.”61 Therefore, it seems plausible that cannabis could be 
regulated as an FDA approved food additive. Proper support from federal 
scientific data and pre-market approval from the FDA, or an act of Congress, 
will be necessary. For now, cannabis is currently categorized as an 
unapproved food additive. 
 
1.3.2 New Dietary Ingredient 
 
The Dietary Supplement Health and Education Act of 1994 broadly 
defined the safety regulations for dietary supplements, which are: 
 
[A] product (other than tobacco) intended to supplement the 
diet that bears or contains one or more . . . dietary ingredients: a 
vitamin, a mineral, an herb or other botanical, an amino acid, dietary 
substance for use by man to supplement the diet by increasing the 
total dietary intake; or a concentrate, metabolite, constituent, extract, 
or combination of any ingredient described [above].62 
 
A dietary supplement is unadulterated if it “contains only dietary 
ingredients . . . present in the food supply” which “ha[ve] not been 
chemically altered” or have a history of safety when used under the 
 
 57. 21 U.S.C.A. § 348(c)(1)(A) (West 2019). 
 58. 21 U.S.C.A. § 348(c)(4)(B) (West 2019). 
 59. FDA Regulation of Cannabis and Cannabis-Derived Products: Questions and Answers, FDA, 
https://www.fda.gov/newsevents/publichealthfocus/ucm421168.htm (last visited Oct. 19, 2019). 
 60. Id. 
 61. Food Additive Amendment of 1958, S. Rep. 85-2422, 2d Sess., at 6 (1958). 
 62. 21 U.S.C.A § 321(ff)(1) (West 2019). 
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conditions clearly proscribed upon the label.63 Most notably, dietary 
ingredients in supplements are not subject to the same pre-market approval 
process as food additives, regardless of being qualified as GRAS.64 
Additionally, at least 75 days before entering interstate commerce, the 
manufacturer or distributor must provide the Secretary of Health and Human 
Services with scientific data upon which they based their safety assessment 
of the ingredient.65 The FDA warns that “selling unapproved products with 
unsubstantiated therapeutic claims can put patients and consumers at risk.”66 
No cannabis-derived products have been fully evaluated by the FDA, and 
thus, those on the market may contain other ingredients that are not properly 
disclosed, posing a consumer hazard.67 
Moreover, there is ample scientific research being conducted on 
cannabis’ effects on the health of humans, and the FDA has concluded THC 
products are “excluded from the dietary supplement definition under 
§201(ff)(3)(B) of the FD&C Act.”68 An exception to §201(ff)(3)(B) is if the 
“substance was ‘marketed as’ a dietary supplement or as a conventional food 
before the drug was approved or before the new drug investigations were 
authorized,”—the FDA has also determined “this is not the case for THC.”69 
Although scientific data can be submitted to rebut this exclusion, a current 
review of presented information has “not caused us [the FDA] to change our 
conclusions.”70 This exclusion applies until the FDA issues a “regulation, 
after notice and comment, finding that the article would be lawful under the 
FD&C Act.”71 A regulation exempting THC as a dietary ingredient is 
necessary for the FDA to properly regulate it as such. 
Considering the totality of the circumstances, cannabis should be 
regulated by the FDA as a food additive. It is clear that dietary ingredients 
are much easier to get onto the consumer market since they do not require 
the same stringent pre-market approval as food additives, but safety should 
come before business ease. One of the FDA’s core policy goals is to place 
 
 63. 21 U.S.C.A § 350b(a)(1-2) (West 2019). 
 64. 21 U.S.C.A § 321(s)(6) (West 2019). 
 65. 21 U.S.C.A § 350b(a)(2) (West 2019). 
 66. Gottlieb, supra note 43. 
 67. Id. 
 68. 21 U.S.C.A. § 321(ff)(3)(B) (West 2019); FDA, supra note 59; FDA Regulation of Cannabis 
and Cannabis-Derived Products: Questions and Answers, FDA, https://www.fda.gov/newsevents/publi 
chealthfocus/ucm421168.htm (last visited Apr. 22, 2019); John A. Gilbert & Larry K. Houck, Medical 
Cannabis Research Act Stirs DEA Marijuana Registration Pot, FDA LAW BLOG (Apr. 10, 2019), http:// 
www.fdalawblog.net/2019/04/medical-cannabis-research-act-stirs-dea-marijuana-registration-pot/; 
Current Studies, CENTER FOR MEDICINAL CANNABIS RESEARCH, https://www.cmcr.ucsd.edu/ind 
ex.php/studies/active-studies (last visited Apr. 23, 2019). 
 69. Id. 
 70. Id. 
 71. Id. 
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safe products on the market, as such, cannabis would best fit under the food 
additives regulation. As a food additive, the FDA could place reasonable 
restrictions and requirements for labeling and safe use by consumers. 
California continues to conduct research on cannabis and its effects on 
humans, and it is likely that the state (and others) will be able to provide the 
FDA with a reasonable certainty that cannabis does not present a significant, 
or unreasonable, risk of illness or injury. 
 
2. REGULATORY REQUIREMENTS FOR  
EDIBLE CANNABIS PRODUCTS 
 
Once a regulatory free-for-all, edible cannabis products are now heavily 
regulated in California. Regulation of edibles currently fall under the 
purview of the BCC and the CDPH. The CDFA is also in charge of the state’s 
track-and-trace system, which is crucial to the regulatory scheme and the 
production of edibles.72 Edible cannabis products are intended for oral 
human consumption, including those which “dissolve or disintegrate in the 
mouth,” and includes “tinctures, capsules and tablets.”73 The regulations 
cover every integral part of the edible manufacturing process through their 
placement in retail dispensaries.  
 
2.1 MANUFACTURING 
 
2.1.1 CDPH Manufacturing Requirements for Edible Products 
 
Obviously, a manufacturer would want to start with a quality, 
uncontaminated flower from which to manufacture their cannabis edibles. 
“Manufacturing cannabis” is defined as “all aspects of the extraction process, 
infusion process, and packaging and labeling processes, including 
processing, preparing, holding, and storing of cannabis products and 
components and ingredients.”74 Manufacturers who produce edible products 
through extraction must obtain a Type N license and may package and label 
all products on-site of the licensed premise.75 The manufacturing process 
regulations are particularly concerned with good production practices to 
 
 72. Track-and-trace is a seed-to-sale program that tracks cannabis from the clone to consumer. 
Flower is given a unique identifier number, which is entered into a statewide online accessible system. 
This tracking allows for quick identification of where the cannabis was cultivated, where the cannabis 
was manufactured, tested, distributed and the retail store it is sold in. See CAL BUS. & PROF. CODE § 
26067 (2019). 
 73. CAL. CODE REGS. tit. 17, § 40100(q) (2019); CAL. CODE REGS. tit. 17, § 40100(hh) (2019). 
 74. CAL. CODE REGS. tit. 17, § 40100(ee) (2019). 
 75. CAL. CODE REGS. tit. 17, § 40118 (c)(1-2) (2019). 
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ensure a quality product. Employees must be properly trained in health and 
safety hazards, emergency response, security, quality control, record 
keeping, security, work safety, and cleanliness.76 Licensees producing edible 
products must also require employees to obtain a “CA food handler 
certificate with from an entity accredited by the American National 
Standards Institute” within 90 days of employment .77 
The multitude of prohibitions related to the production of edible 
cannabis act solely as safeguards for the public health. Edibles may not 
contain alcohol, nicotine, or caffeine additives, but this does not apply to 
“naturally occurring caffeine . . . i.e. coffee, tea, or chocolate.”78 Edibles may 
not contain meat (except dried meat products), seafood, dairy products, or 
anything that requires it “be held at or below 41 degrees Fahrenheit.”79 All 
food ingredients, or components used, must be “permitted by the United 
States Food and Drug Administration for use in food or food manufacturing, 
as specified in Substances Added to Food in the United States . . . or is 
GRAS” under the FDCA.80 
 
2.1.2 FDA Good Manufacturing Practices for Dietary Supplements 
 
Under the standards set by the FDA’s “Current Good Manufacturing 
Practice in Manufacturing, Packaging, Labeling, or Holding Operations for 
Dietary Supplements,” dietary supplements face stringent manufacturing 
process controls that ensure supplements contain what the manufacturer 
intends them to contain.81 The CGMPs establish requirements for laboratory 
controls and testing methods, including robust requirements to conduct 
quality control on labeling and packaging.82 Cleanliness, uniformity, and 
homogeneity are all policy goals espoused by the CGMPs. 
 
2.1.3 BCC Testing Requirements for Manufacturers 
 
The strict testing requirements for cannabis flowers and subsequent 
cannabis products have proven to be a web of complicated regulatory 
standards to meet. The BCC requires testing laboratories offering tests of 
cannabis goods in California to obtain and maintain an ISO/IEC 17025 
 
 76. CAL. CODE REGS. tit. 17, § 40280(a) (2019). 
 77. CAL. CODE REGS. tit. 17, § 40280(a)(3) (2019). 
 78. CAL. CODE REGS. tit. 17, § 40300 (a-b) (2019). 
 79. CAL. CODE REGS. tit. 17, § 40300(c) (2019); CAL. CODE REGS. tit. 17, § 40300(g-i) (2019). 
 80. CAL. CODE REGS. tit. 17, § 40305(a) (2019); 21 U.S.C.A. § 321(s) (West 2019); 21 U.S.C.A. § 
348 (West 2019). 
 81. See generally 21 C.F.R. § 111 (2019). 
 82. 21 C.F.R. § 111.315 (West 2019); 21 C.F.R. § 111.160 (West 2019). 
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accreditation, an internationally recognized standard.83 This accreditation is 
expensive because the testing staff must employ scientists with expertise in 
chemistry and microbiology and use the same equipment used in the food 
and pharmaceutical industries, including robotics.84 Testing laboratories are 
required to ensure that the presence of contaminants does not exceed the 
levels set forth by the Bureau, standards made in conjunction with the 
American Pharmacopoeia monograph and the Department of Pesticide 
Regulation.85 
Testing for cannabis flower and products was rolled out in three phases. 
Phase 1 testing began on January 1, 2018, and required testing for 
cannabinoids, category I pesticides, category II solvents and processing 
chemicals testing, microbial impurities, and moisture content.86 Edible 
products were exempt from the moisture content and microbial impurities 
testing for A. fumigatus, A. flavus, A. niger, A. terreus, but were tested for 
homogeneity.87 Phase 2 went into effect on July 1, 2018, requiring all Phase 
I elements plus category I solvents and processing chemicals, category II 
residual pesticides, and foreign material.88 Phase 3 took effect December 31, 
2018, requiring all Phase 1 and 2 testing, in addition to terpenoids, 
mycotoxins, heavy metals, and water activity testing of solid and semi-solid 
edibles.89 Cannabis products that do not meet these testing requirements 
must be destroyed or remediated, if possible.90 The laboratory test results are 
then articulated and issued in a certificate of analysis.91 
Unlike cannabis flowers, edible cannabis products cannot be 
remediated and must be destroyed if they do not pass regulatory testing 
requirements.92 Arguably, the most pertinent testing of edibles is for 
 
 83. Testing Laboratories, BUREAU OF CANNABIS CONTROL, https://www.bcc.ca.gov/licensees/testi 
ng_labs.html (last visited Apr. 22, 2019); CAL. BUS. & PROF. CODE § 26100(g) (2019) (defining “GRAS” 
to mean generally recognized as safe by the FDA). 
 84. California Marijuana Products Delayed by Backlogs in Testing Labs, NBC NEWS SAN DIEGO 
(Aug. 6, 2018, 6:01 PM), https://www.nbcsandiego.com/news/local/California-Marijuana-Products-
Delayed-by-Backlogs-in-Testing-Labs-490191141.html. 
 85. CAL BUS. & PROF. CODE § 26100(1)(H)(2) (2019). 
 86. Microbial impurities tested: A. fumigatus, A. flavus, A. niger, A. terreus and Escherichia coli 
and Salmonella spp. See Laboratory Testing, BUREAU OF CANNABIS CONTROL, https://bcc.ca.gov/abou 
t_us/documents/17-261_required_testing_chart.pdf (2018). 
 87. Id. 
 88.  Id.; see also Melissa Schiller, California Prepares to Roll Out Additional Cannabis Testing 
Regulations July 1, CANNABIS BUSINESS TIMES (June 18, 2018), https://www.cannabisbusinesstimes. 
com/article/california-additional-testing-regulations-july-1/. 
 89.  BUREAU OF CANNABIS CONTROL, supra note 86. 
90.  Oren Bitan, Testing Mandate is Straining California Cannabis Companies, LAW360 (Aug. 9, 
2018, 2:16 PM), https://www.law360.com/foodbeverage/articles/1071661/testing-mandate-is-straining-
california-cannabis-cos-. 
 91. CAL. BUS. & PROF. CODE § 26100(d) (2019). 
 92. CAL. BUS. & PROF. CODE § 26104(b)(3) (2019); CAL. CODE REGS. tit. 17, § 40330(c) (2019). 
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measurements of cannabinoids, wherein all edibles must not exceed 10mg of 
THC per serving or no more than 100mg THC per package.93 However, if an 
edible product fails the testing requirements solely because the product 
exceeded the “per package limit of THC,” it can be remediated on a case-by-
case basis approved by the CDPH, only if it can be returned to the distributor 
and repackaged but not altered in any way.94 
 
2.1.4 Known Complications with Current Testing Requirements 
 
Within the first two months of Phase 2 testing requirements, the BCC 
reported that one in five pot samples were being “red stamped,” i.e., were 
failing a required test.95 Phase 3 was initially slated to cause laboratory 
testing fees to “increase by 40-55% for some of the state’s licensed cannabis 
cultivators as well as makers of concentrates and infused products.”96 
Consequently, as of December 2018, there were only 52 licensed 
laboratories in the state, and only 14 of those labs were confirmed to offer 
Phase 3 compliance testing.97 Naturally, a significant backlog occurred.98 
Early soil and flower samples were being tested for heavy metals at 10-20 
times the legal allowance.99 Between July and November 2018, 2,100 of 
23,864 batches of various cannabis products failed due to overestimation of 
THC content, and 739 of those same 23,864 failed for pesticides.100 Though 
this is only a fourteen percent failure rate, cannabis edibles have faced the 
 
 93. CAL. BUS. & PROF. CODE § 26130(c)(2) (2019); CAL. CODE REGS. tit. 17, § 40315(a)(1-2) (2019) 
(orally dissolving products and non-orally dissolving medical use edible cannabis, that is labeled “FOR 
MEDICAL USE ONLY” may contain up to 500 milligrams and 100 milligrams per package, 
respectively). 
 94. CAL. CODE REGS. tit. 17, § 40330(e-f) (2019). 
95.  Bitan, supra note 90. 
 96.  For example, Somatik, a company that makes cannabis-infused cold brew-coffee expected 
“costs to increase more than 40%, from $620 to $890 per batch.” Similarly, cannabis company Nug’s 
edibles and concentrates were to “increase nearly 50%, from $615 to $915 for its edibles and $665 to 
$965 for its concentrates.” Joey Peña, California Marijuana Industry Braces For ‘Another Enormous 
Burden’ From Next Phase of Testing Costs, MARIJUANA BUSINESS DAILY (Dec. 20, 2018), https:// 
mjbizdaily.com/california-marijuana-phase-3-testing-costs/. 
 97. Id. 
 98. California Marijuana Products Delayed by Backlogs in Testing Labs, NBC SAN DIEGO (Aug. 7, 
2018, 9:48 AM), https://www.nbcsandiego.com/news/local/California-Marijuana-Products-Delayed-by-
Backlogs-in-Testing-Labs-490191141.html; Bitan, supra note 90. 
99.  Peter Fimrite, Recall Deals Blow to California’s Marijuana Industry, SAN FRANCISCO 
CHRONICLE (Dec. 23, 2018, 2:57 PM), https://www.sfchronicle.com/news/article/Recall-deals-blow-to-
California-s-marijuana-13487748.php. 
 100. Amelia McDonell-Parry, Pot in California: What’s Going on With Cannabis Testing?, ROLLING 
STONE (Dec. 17, 2018, 5:16 PM), https://www.rollingstone.com/culture/culture-news/california-weed-
testing-cannabis-lab-770320/; Fimrite, supra note 99. 
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most difficulty in meeting current standards.101 Phase 3 heavy metal testing 
requirements will very likely continue to be one of “the biggest challenges 
for cultivators and product manufacturers” because there is not enough data 
yet to predict trends.102 Additionally, some labs have failed industry 
standards, thus, sacrificing the public safety by falsifying testing results.103 
Laboratories are essential gatekeepers in the cannabis industry and it is 
crucial that laboratories strictly adhere to state regulations for the sake of the 
publics’ safety. If followed, these stringent testing regulations will lessen the 
chance of contamination and likely ensure homogeneity. 
 
2.2 LABELING AND PACKAGING REQUIREMENTS 
 
2.2.1 CDPH Packaging Requirements for Edible Products 
 
Once a product is manufactured and tested, the product is then 
packaged for retail distribution. CDPH packaging requirements largely 
focus on public safety, particularly on keeping edibles unattractive to 
children and preventing overconsumption by adults. Edibles must clearly 
delineate one serving (10mg) or be packaged so one serving is “readily 
identifiable or easily measurable.”104 Edibles containing more than one 
serving must be “homogenized so that each serving contains the same 
concentration of THC.”105 Products must not be packaged so as to be 
“easily confused with commercially available foods that do not contain 
cannabis,” or shaped or imprinted with the shape of a “human being, 
animal, insect or fruit.”106 The CDPH also requires all products to be 
tamper-evident and child-resistant throughout the duration of its use, and 
must be packaged and sold in opaque packaging.107 Cannabis products must 
 
101.  In this context, edibles include cookies, candies, and tinctures. Id. 
 102. Fimrite, supra note 99. 
 103. McDonell-Parry, supra note 100; John Schroyer, Falsified California Testing Lab Data May 
Result in Major Marijuana Product Recall, MARIJUANA BUSINESS DAILY (Dec. 3, 2018), https://  
mjbizdaily.com/falsified-california-testing-lab-data-may-result-in-major-marijuana-product-recall/. In 
November 2018, Sequoia Analytical Labs of Sacramento voluntarily handed over their license after 
failing to test for all 66 types of pesticides and contaminants (Sequoia was only testing for 44) and for 
secretly falsifying lab results. Despite the immediate recall for retesting and mandate of certain products 
tested by the lab to be destroyed, a majority of the product (between 700-800 batches of product, and tens 
of thousands of pounds of flower and oils) had likely already been consumed, obviously to the detriment 
and safety of the consumer. Testing laboratories that do not follow state regulations will be forced to 
forfeit their testing licenses to the state. Fimrite, supra note 99. 
 104. CAL. CODE REGS. tit. 17, § 40305(b)(1)(-2) (2019). 
 105. CAL. CODE REGS. tit. 17, § 40305(c) (2019). 
 106. CAL. CODE REGS. tit. 17, § 40300(l)-(m) (2019). 
 107. CAL. CODE REGS. tit. 17, § 40415(b)-(c) (2019); & CAL. CODE REGS. tit. 17, § 40415(g) (2019); 
CAL. CODE REGS. tit. 17, § 40417(a)(1) (2019); CAL. CODE REGS. tit. 17, § 40415(e) (2019); CAL. CODE 
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be in finished form for sale before release to distributors for retail.108 
 
2.2.2 CDPH Labeling Requirements for Edible Products 
 
Proper labeling is crucial for safe consumption. There are two parts to 
a label: the primary panel and the informational panel, typically on the 
back.109 Labels cannot be attractive to children in any capacity and may not 
imitate candy or use the language “candy” (or any variation of the word).110 
An edible’s primary label must contain the identity of the product and the 
universal symbol (as prescribed in § 40412).111 The primary label must 
include “the words ‘cannabis-infused’ immediately above the identity of the 
product in bold type and a text size larger than the text size used for the 
identity of the product.”112 
The informational panel must contain any known major food allergens, 
artificial colorings, list of ingredients (in descending order by weight or 
volume), amount of sodium, sugar, carbohydrates and fat per serving, 
instructions for “method of consumption,” “best by” date, and UID 
number.113 All informational panels must also contain a boldfaced, all caps 
government warning.114 The label may not contain any false or misleading 
information, any unsubstantiated health-related statements, and must adhere 
to Prop. 65 requirements including a warning stating that “this product can 
 
REGS. tit. 17, § 40401(a) (2019). 
 108. CAL. CODE REGS. tit. 17, § 40401(a) (2019). 
109.  CAL. CODE REGS. tit. 17, § 40100(nn) (2019); CAL. CODE REGS. tit. 17, §§ 40405-40406 (2019) 
(primarily labeled as “part of the package most likely to be displayed to the consumer at retail” and 
informationally paneled “any other portion of the label”); CAL. CODE REGS. tit. 17, § 40408 (2019); 21 
U.S.C. § 321(k)-(m) (2019) (defining the label as the explanatory matter upon the “immediate container 
of any article” and labeling includes the label and any accompanying matter). 
 
 110. CAL. CODE REGS. tit. 17, § 40410(b) (2019).  
 111. CAL. CODE REGS. tit. 17, § 40405(a) (2019). 
 112. CAL. CODE REGS. tit. 17, § 40406 (2019) (emphasis added). 
 113. CAL. CODE REGS. tit. 17, § 40408(a)(6)-(12)(2019). 
 114. CAL. CODE REGS. tit. 17, § 40408(a)(3) (2019) (stating that Government warning required for 
cannabis products: “GOVERNMENT WARNING: THIS PRODUCT CONTAINS CANNABIS, A 
SCHEDULE I CONTROLLED SUBSTANCE. KEEP OUT OF REACH OF CHILDREN AND 
ANIMALS. CANNABIS PRODUCTS MAY ONLY BE POSSESSED OR CONSUMED BY PERSONS 
21 YEARS OF AGE OR OLDER UNLESS THE PERSON IS A QUALIFIED PATIENT. THE 
INTOXICATING EFFECTS OF CANNABIS PRODUCTS MAY BE DELAYED UP TO TWO 
HOURS. CANNABIS USE WHILE PREGNANT OR BREASTFEEDING MAY BE HARMFUL. 
CONSUMPTION OF CANNABIS PRODUCTS IMPAIRS YOUR ABILITY TO DRIVE AND 
OPERATE MACHINERY. PLEASE USE EXTREME CAUTION”). 
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expose you to a chemical known to the State of California to cause 
cancer.”115 Cannabis products may also contain “information on the 
characteristic anticipated effects” if the “manufacturer has substantiation that 
the information is truthful and not misleading,” and can include any common 
or expected physiological effects.116 
 
2.2.3 FDA Regulation of Labeling and Packaging of Dietary Supplements 
and Food Additives 
 
The FDA requires dietary supplement labels to contain basic 
components such as, an identity statement, net quantity of contents 
statements, ingredient statement, responsibility statement (name and place 
of business of manufacturer or distributor), and a nutrition statement that 
includes “Nutrition Facts and “Supplement Facts.”117 Similarly to edible 
labels, supplement labels are prohibited from making any unsubstantiated 
health claims.118 Food additives must be labeled with “directions for safe use, 
and any specific limitation” for use.119 If no such limitations exist, the label 
“must include information concerning the levels of the chemical that may be 
used in a manner consistent with good manufacturing practices.”120 
 
2.3 DISTRIBUTION AND RETAIL 
 
2.3.1 BCC Distribution and Retail Requirements 
 
Quality control and child-safety are essential for the success of a 
distributor and, thus, the BCC heavily regulates distributors because their 
non-compliance can impact the entire industry. Distributors must ensure that 
they are only working with properly licensed vendors and that all products 
comply with proper packaging requirements.121 All edible packaging must 
 
 115. CAL. CODE REGS. tit. 17, § 40410(c)-(d) (2019) (“Any health-related statement must be 
supported by the totality of publicly available scientific evidence (including evidence from well-designed 
studies conducted in a manner which is consistent with generally recognized scientific procedures and 
principles), and for which there is significant scientific agreement, among experts qualified by scientific 
training and experience to evaluate such claims”); CAL. BUS. & PROF. Code § 26121 (2019); CAL. BUS. 
& PROF. Code § 26154 (2019); Burton & May, supra note 15, at 4. 
 116. CAL. CODE REGS. tit. 17, § 40411 (2019) (emphasis added). 
 117. Nathalie Bougenies, Hemp-CBD and FDA: Labeling Dietary Supplements, CANNA LAW BLOG 
(Jan. 4, 2019), https://www.cannalawblog.com/hemp-cbd-and-fda-labeling-dietary-supplements/. 
 118. Id. 
 119. U.S. FOOD & DRUG ADMINISTRATION, CPG Sec. 500.250 Food Additives – Labeling Directions 
Necessary For Safe Use, https://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanc 
eManual/ucm074414.htm (last visited Oct. 19, 2019). 
 120. Id. 
 121. CAL. BUS. & PROF. CODE § 26120(a) (2019); Melissa Schiller, 4 Things Your Distributor Wants 
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not imitate any package commonly marketed towards children and must be 
child-resistant.122 To be certified child-resistant, packaging must comport 
with the “requirements of the Poison Prevention Packaging Act of 1970” or 
must be plastic and “at least 4 mils thick and heat-sealed without an easy-
open tab, dimple, corner, or flap.”123 Most importantly, the BCC requires 
distributors to perform a quality-assurance review for the labeling of total 
cannabinoids and terpenoids claimed to be present; products are considered 
accurate if they are within “plus or minus 10.0%” of what is stated on the 
certificate of analysis.124 
 
2.3.2 BCC Retail Requirements 
 
Edible packaging is largely under the jurisdiction of the CDPH; 
however, the BCC also articulates a few additional requirements. Cannabis 
goods must adhere to the strict exit packaging requirements articulated in the 
CDPH regulations—all goods must be placed in a “resealable, tamper-
evident, and child resistant” opaque package.125 Retailers are also strictly 
prohibited from packaging “accept[ing], possess[ing,] or selling” any 
cannabis goods which are not already properly packaged for final sale.126 
 
2.3.3 FDA Tamper-Evident Guidelines 
 
Similarly, the FDA has guidelines to safeguard products and notify 
consumers if they were opened. Tamper-evident packaging is defined by the 
FDA as “having one or more indicators or barriers to entry which, if breached 
or missing, can reasonably be expected to provide visible evidence to 
consumers that tampering has occurred,” which would hopefully mitigate 
prior sale liability.127 The World Health Organization, whose standards are 
considered by the FDA and National Association of Cannabis Businesses, 
strongly believes tamper-evident packaging will protect not only a product, 
 
You to Know, CANNABIS BUSINESS TIMES (Sept. 7, 2018); see generally CAL. BUS. & PROF. CODE § 
26110 (2019). 
 122. CAL. BUS. & PROF. CODE § 26120 (b) (2019); CAL. BUS. & PROF. CODE § 26120 (a)(1)(B)(9)(d) 
(2019). 
 123. CAL. CODE REGS. tit. 17, § 40417(b)-(c) (2019); POISON PREVENTION PACKAGING ACT OF 1970, 
16 C.F.R. §1700.15(b)(1) (Rev. July 1995). 
 124. A Certificate of Analysis is issued by a laboratory post-testing with results of required analytes. 
The results are reported to the BCC and must be accurately reflective at all times. CAL. BUS. & PROF. 
CODE § 26110(e)-(f) (2019). 
 125. CAL. BUS. & PROF. CODE § 26070.1 (2019); CAL. BUS. & PROF. CODE § 26120 (a) (2019). 
 126. CAL. BUS. & PROF. CODE § 26120 (a) (2019). 
127.  21 C.F.R § 211.132(b) (2019); Burton & May, supra note 15, at 30. 
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but also its consumer against both incidental and accidental poisoning.128 
 
2.4 Policy Goals of the California Regulations: Public Health and Safety 
 
Ultimately, current edibles regulations strive to protect the public health 
and safety. Both the CDPH and the BCC have promulgated guidelines that 
strive for consumers to purchase edibles “free from contaminants, [that] meet 
product guidelines and are properly packaged and labeled.”129 At every level 
of the manufacturing chain, there are safeguards to protect the consumer: 
exhaustive testing requirements for all cannabis flower and completed 
edibles, good manufacturing guidelines to ensure homogeneity which 
correlates to the proper labeling, combing stringent tamper-evident, and 
child-resistant packaging.130 Still, things can go wrong, and suits may arise. 
Even if a California cannabis edible manufacturer follows all of these 
guidelines, including the possible FDA regulations, there are additional steps 
needed to lessen the possibility of a product liability lawsuit. 
 
3. PRODUCT LIABILITY ISSUES WITH  
CANNABIS EDIBLE PRODUCTS 
 
3.1 LEGAL STANDARD 
 
Edibles are unique in that product liability exposure can arise from it 
being both a food and an intoxicating substance. Cannabis edibles are 
 
 128.  Burton & May, supra note 15, at 7; see generally NACB National Standards: Packaging and 
Labeling, NATIONAL ASSOCIATION OF CANNABIS BUSINESSES (May 17, 2018), https://www.nacb.com/ 
national-standards-packaging;NACB National Standards: Advertising Standards, NATIONAL 
ASSOCIATION OF CANNABIS BUSINESSES (Nov. 5, 2018), https://www.nacb.com/national-advertising-
standards. The National Association of Cannabis Businesses (NACB), the only self-regulatory 
organization for the U.S. cannabis industry, requires all members to maintain compliance with set 
standards or face expulsion. In the face of federal prohibition, the NACB has promulgated industry 
standards for packaging, advertising, and lab testing and product integrity. These standards could 
potentially be used as guidance in states that do not already have a statute for strict products liability, (not 
the case in California. The FDA could also use these standards as guidance in setting their own future 
policies. NACB President Andrew Kline posits that if NACB “set standards that are higher than what 
they’re required to do in their states, the federal government will stay out of their way.” See NACB 
National Standards: Lab Testing and Product Integrity, Public Comment Now Closed, NATIONAL 
ASSOCIATION OF CANNABIS BUSINESSES (accessed Feb. 17, 2019), https://www.nacb.com/national-lab-
testing-product-integrity-standards. Burton & May, supra note 15, at 7; WHO Technical Report Series, 
NO. 902 – §1.5 Protection of Patients, WORLD HEALTH ORGANIZATION 131 (2002), http://apps.who.int/ 
medicinedocs/documents/s19638en/s19638en.pdf 
 129.  CALIFORNIA DEPARTMENT OF PUBLIC HEALTH: MANUFACTURED CANNABIS SAFETY BRANCH, 
https://www.cdph.ca.gov/Programs/CEH/DFDCS/MCSB/Pages/MCSB.aspx (last visited Oct. 19, 2019). 
130.   See generally CAL. BUS & PROF. CODE §§ 26130 — 26135 (2019); CAL. CODE REGS. tit. 17, ch. 
13, subch. 4 (2019).  
3 - LAZZERI - MACRO - V11 KC - 10.27.19.DOCX (DO NOT DELETE) 11/15/2019  11:12 AM 
84 HASTINGS BUSINESS LAW JOURNAL [Vol. 16:1 
uniquely more potent as compared to when an individual smokes the plant.131 
Edibles also have a much “slower onset time and greater challenge in 
metering dosage.”132 If you get too high you may experience panic, 
hallucinations, anxiety, or feel frightened, although no one has ever died 
from a cannabis overdose.133 Product liability typically arises “from design 
defects, specific language in advertising and inadequate warnings.”134 
Product liability claims only cover physical injury, and the person harmed 
must have used the product “in a way that was reasonably anticipated by the 
manufacturer.”135 The plaintiff has the initial burden of proof of injury when 
using the product in “an intended or reasonably foreseeable manner.”136 If 
proven, the defendant must then “prove that the plaintiff’s injury resulted 
from a misuse of the product.”137 If the product is proven to be the sole cause 
of injury, its misuse is a “complete defense to strict product liability.”138 In 
California, if misuse or modification is not the sole, but rather a substantial 
factor in injury, comparative fault of plaintiff or of a third-person is 
weighed.139 However, California has a strict liability standard for three types 
of defects: manufacturing, design, and warning.140 Manufacturing defects 
claims arise out of “errors in the process of making the product.”141 “Design 
defects focus . . . on the design itself,” and warning defects arise out of a 
manufacturers failure to warn.142 
“The purpose of such [strict] liability is to insure that the costs of 
 
 131. Campbell & Singh, supra note 4, at 345; see also, Donald W. Sieveke, California’s Changing 
Marijuana Laws Grow New Opportunities, 59 ORANGE COUNTY LAWYER 42, 46 (2017). 
 132. Neil Juneja, Are Cannabis Retailers & Producers Liable for Consumer Harm?, GLEAM LAW 
(2018), https://www.gleamlaw.com/cannabis-product-liability/. 
 133. How Does Marijuana Affect You?, WEBMD, https://www.webmd.com/mental-health/marijua 
na-use-and-its-effects#1 (last visited Oct. 19, 2019); Lisa Rough, 8 Ways to Counteract a Too-Intense 
Cannabis High, LEAFLY, https://www.leafly.com/news/cannabis-101/8-ways-to-counteract-a-too-inten 
se-cannabis-high (last visited Oct. 19, 2019). 
  134.  Burton & May, supra note 15, at 30. 
 135. Campbell & Singh, supra note 4, at 349; Ian A. Stewart & Francis J. Mootz III, Insuring the 
Product Liability Risks of Cannabis, SSRN 1 (Sept. 1, 2017), https://papers.ssrn.com/sol3/papers.cfm 
?abstract_id=3111600; CACI § 1200 – Strict Liability 669 (2017); Johnson v. United States Steel Corp, 
192 Cal.Rptr.3d 158, 164 (Cal. Ct. App. 2015). 
 136. Stewart & Mootz III, supra note 135.  
 137. Id. 
 138. Id. 
 139. Id. 
 140. Anderson v. Owens-Corning Fiberglas Corp., 53 Cal.3d 987, 995 (Cal. 1991); see also, Lauren 
M. Case, Latosha M. Ellis, Alana Long, Lindsay L. Rollins, & Cassandra C. Shivers, How High: The 
Buzz on Emerging Issues in Coverage for Cannabis Operations, AMERICAN BAR ASSOCIATION 18 n.2 
(Aug. 21, 2018), https://www.americanbar.org/content/dam/aba/administrative/litigation/materials/regi 
onals-materials/2018-2019/win/8-Coverage-for-Cannabis-Operations/WIN-How-High-The-Buzz-on-E 
merging-Issues-in-Coverage-for-Cannabis-Oper.pdf; Stewart & Mootz III, supra note 135. 
 141. Campbell & Singh, supra note 4, at 350. 
 142. Id. 
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injuries resulting from defective products are borne by the manufacturers” 
and not by “the injured persons who are powerless to protect themselves.”143 
Every integral part of the manufacturing chain is considered liable for a final 
product that induces injury.144 “A defendant will not be held strictly liable 
unless doing so will enhance product safety, maximize protection to the 
injured plaintiff, and apportion costs among the defendants.”145 
[T]o hold a defendant strictly liable under a marketing/distribution 
theory, the plaintiff must demonstrate that the defendant: (1) received a direct 
financial benefit from its activities and from the sale of the product; (2) 
played an integral role in the business enterprise, such that the defendant’s 
conduct was a necessary factor in bringing the product to the initial consumer 
market; and (3) had control over, or a substantial ability to influence, the 
manufacturing or distribution process.146 
This strict liability standard will certainly pose challenges for edible 
cannabis companies. Cannabis’ current federal illegality “potentially 
undercuts [any first-party] claim” and a court may conclude that this 
establishes liability, if filed in federal court.147 Third-party claims arise out 
of a person injured from someone else’s use of cannabis, and are more likely 
to be filed because the federal illegality “potentially helps the claims.”148 
Manufacturers and retailers are typically liable for placing “unreasonably 
dangerous products on the market,” however, what is considered 
“unreasonably dangerous” is determined by community standards and 
expectations.149 Since THC has been federally illegal, except for medicinal 
patients under various states’ laws, what constitutes community standards 
and expectations may be difficult for courts to articulate.150 
 
 
 
 143. CACI § 1200 - Strict Liability 670 (2017); Greenman v. Yuba Power Products, Inc., 59 Cal.2d 
57, 62-63 (1963). 
 144. Arriaga v. CitiCapital Commercial Corp., 167 Cal.App.4th 1527, 1534 (2008); Lauren M. Case, 
Latosha M. Ellis, Alana Long, Lindsay L. Rollins, & Cassandra C. Shivers, How High: The Buzz on 
Emerging Issues in Coverage for Cannabis Operations, AMERICAN BAR ASSOCIATION 18 n.2 (Aug. 21, 
2018), https://www.americanbar.org/content/dam/aba/administrative/litigation/materials/regionals-mate 
rials/2018-2019/win/8-Coverage-for-Cannabis-Operations/WIN-How-High-The-Buzz-on-Emerging-Iss 
ues-in-Coverage-for-Cannabis-Oper.pdf.; Stewart & Mootz III, supra note 135. 
 145. Hernandezcueva v. E.F. Brady Co., Inc., 243 Cal.App.4th 249, 258 (2015); CACI § 1200 – Strict 
Liability 670-71 (2017). 
 146. Arriaga v. CitiCapital Commercial Corp., 167 Cal.App.4th 1527, 1535 (2008); CACI § 1200 – 
Strict Liability 670-71 (2017). 
 147. Campbell & Singh, supra note 4, at 351-52. 
 148. Id. 
 149. Neil Juneja, Are Cannabis Retailers & Producers Liable for Consumer Harm?, GLEAM LAW 
(July 12, 2018), https://www.gleamlaw.com/cannabis-product-liability/. 
 150. Id. 
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3.2 PRODUCT LIABILITY CASES IN CANNABIS 
 
At the time of writing, there has not been a product liability lawsuit 
related to edible cannabis in California. However, in 2016, the first cannabis 
third-party liability case was filed in the Denver District Court, Kirk v. 
Nutritional Elements, Inc., and Gaia’s Garden.151 Gaia’s Garden was a 
medical marijuana bakery that produced THC edibles.152 Richard Kirk 
consumed a candy with 101 mg of THC, ten-times the recommended dosage 
for edibles, and experienced “possible psychotic behavior” and 
hallucinations.153 He got his gun and shot and killed his wife in front of their 
three children.154 Kirk’s children filed suit alleging the bakery and 
distributor, Nutritional Elements, Inc., failed “to warn that edibles could lead 
to paranoia, psychosis and hallucinations” and “negligently, recklessly and 
purposefully concealed vital dosage and labeling information from their 
actual and prospective purchasers . . . to make a profit.”155 Kirk ended up 
pleading guilty to second-degree murder, agreeing to serve 25-30 years in 
prison and giving up custody of his three children.156 Kirk’s plea deal ended 
a years-long debate surrounding cannabis and its influence on the slaying; 
coincidentally, he was later determined to not have been intoxicated by 
cannabis.157 The only other product liability suit was also filed in the Denver 
 
 151. Kirk v. Nutritional Elements, Inc., and Gaia’s Garden, No. 16-cv-31310, complaint filed (D. 
Colo. April 13, 2016), https://www.courthousenews.com/wp-content/uploads/2017/05/Kirk.v.Gaia_.pdf; 
see also, Lauren M. Case, Latosha M. Ellis, Alana Long, Lindsay L. Rollins & Cassandra C. Shivers, 
How High: The Buzz on Emerging Issues in Coverage for Cannabis Operations, AMERICAN BAR 
ASSOCIATION 18 (Aug. 21, 2018), https://www.americanbar.org/content/dam/aba/administrative/litigat 
ion/materials/regionals-materials/2018-2019/win/8-Coverage-for-Cannabis-Operations/WIN-How-Hig 
h-The-Buzz-on-Emerging-Issues-in-Coverage-for-Cannabis-Oper.pdf.; Stewart & Mootz III, supra note 
135; Jason Schossler, Insurer Says Marijuana Bakery on its Own for ‘Karma Kandy’ Killing, 27 No. 32 
WJINSC 1 (May 19, 2017). 
 152.  Lauren M. Case, Latosha M. Ellis, Alana Long, Lindsay L. Rollins & Cassandra C. Shivers, 
How High: The Buzz on Emerging Issues in Coverage for Cannabis Operations, AMERICAN BAR 
ASSOCIATION 18 (Aug. 21, 2018), https://www.americanbar.org/content/dam/aba/administrative/li 
tigation/materials/regionals-materials/2018-2019/win/8-Coverage-for-Cannabis-Operations/WIN-How-
High-The-Buzz-on-Emerging-Issues-in-Coverage-for-Cannabis-Oper.pdf. 
 153. Id. 
 154. Id. 
 155. Hilary Bricken, Killer Pot? An Analysis of the Cannabis Wrongful Death Suit in Colorado, 
ABOVE THE LAW (June 6, 2016), https://abovethelaw.com/2016/06/killer-pot-an-analysis-of-the-cann 
abis-wrongful-death-suit-in-colorado/. 
 156. Id. 
 157. Kirk’s suit ended in a plea deal but the suit filed against Gaia’s Garden and its distributor 
Nutritional Elements continues. Gaia’s insurance, United Specialty, filed a federal complaint against 
Gaia’s Garden and Kirk’s children, denying any obligation to defend Gaia as their policy did not cover 
injury once Gaia had “relinquished possession’ of the product” and excluded liability arising from 
“psychotropic substances.” Jesse Paul, Richard Kirk, Colorado man Accused in Slaying of his Wife, 
Pleads Guildy to Second-Degree Murder, THE CANNABIST (Feb. 3, 2017), https://www.the 
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District Court, Flores v. Liv Well, Inc. There, plaintiffs alleged that the 
cultivator had used the toxic pesticide Eagle 20 (containing Myclobutanil) 
and failed to provide adequate warning.158 However, the case was dismissed 
for lack of standing—plaintiffs had consumed the product without any 
injury.159 In both cases, causation was an issue, and neither plaintiff was 
awarded damages on the merits.160 Causation will certainly be a pertinent 
issue with edible cannabis consumption and liability in the near future. 
 
3.3 MANUFACTURING DEFECTS AND PROPOSED RESPONSE: 
ADDITIONAL RECALL PROCEDURES 
 
Manufacturing defect claims arise from procedural errors in making the 
product. Potential manufacturing defects in cannabis stem from the raw 
flower itself.161 Growers must be diligent about keeping the plants insect and 
pest free, and yet, refrain from exposing the plant to a multitude of 
pesticides.162 When tainted flower is then used to extract THC for edible 
products, the edible will also likely be tainted. To address such 
manufacturing and design defects, California laboratories must adhere to all 
FDA requirements and obtain an ISO/IEC 17025 international 
accreditation.163 Manufacturers must only use food ingredients or 
components that are GRAS by FDA standards. The edible industry is similar 
to the dietary supplement industry’s rise in products on the market before 
proper federal regulation.164 Supplement companies were sued for “strict 
product liability, negligence, breach of warranty, misrepresentation, unfair 
business practices and fraud,” leading to “product recalls and consumer class 
actions” due to “poor-quality control, contamination and misleading product 
claims.”165 The California cannabis industry can avoid the same legal pitfalls 
as the dietary supplement industry by instituting policies that go above and 
 
cannabist.co/2017/02/03/richard-kirk-colorado-murder-marijuana-candyintoxication/72996/. 
 158. Julie A. Steinberg, Pot Product Makers High on Strict Restrictions, LITIGATION ON BLOOMBERG 
LAW (June 22, 2017), https://www.bna.com/pot-product-makers-n73014460652/; see also Campbell & 
Singh, supra note 4, at 357; Stewart & Mootz III, supra note 135. 
 159. Julie A. Steinberg, Pot Product Makers High on Strict Restrictions, LITIGATION ON BLOOMBERG 
LAW (June 22, 2017), https://www.bna.com/pot-product-makers-n73014460652/. 
 160. Thomas Stufano, Through the Smoke: Do Current Civil Liability Laws Address the Unique 
Issues Presented by the Recreational Marijuana Industry?, 34 TOURO L. REV. 1409, 1418 (2018). 
 161. Campbell & Singh, supra note 4, at 353. 
 162. Id. at 353-54. 
163.  Testing Laboratories, CAL. BUREAU OF CANNABIS CONTROL, https://bcc.ca.gov/licensees/testin 
g_labs.html, (last visited Oct. 23, 2019). 
 164. Stewart & Mootz III, supra note 135. 
 165. Prop. 65 institutes warning requirements for all products sold in California, known to the state, 
that may expose an individual to a chemical that may cause cancer. There are more than 1,000 chemicals 
currently listed. For more information, visit www.P65Warnings.ca.gov. Id.  
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beyond the current California and FDCA regulations of dietary supplements 
or food additives, which will include incorporating additional recall 
procedures. 
Under California law, the CDPH is the only agency with recall authority 
and requires all licensees to create and “implement written procedures for 
recalling cannabis products manufactured by the licensee that are determined 
to be misbranded or adulterated.”166 If the Department “has evidence” a 
product is “adulterated or misbranded,” and the use will “cause serious 
adverse health consequences,” the department will notify the manufacturer; 
a voluntary recall will be requested and a hearing is provided, unless the 
Department believes a mandatory recall is necessary.167 Information 
regarding recalled products must be located in the CDFA track-and-trace 
system, likely enabling manufacturers to get products off the market before 
widespread consumption. Thus, all cannabis companies must not only have 
recall procedures in place—that are routinely tested by compliance 
departments—but also aggressive public notifications, as required by the 
FDA.168 Such notifications should include press releases to consumers who 
may have purchased the product, including a picture of it on the website of 
the dispensary, the BCC, and on the local news. Timely and coordinated 
communication with all agencies and actors is tantamount to public safety 
during a recall. Cannabis companies are required to obtain insurance in 
California, however, product liability insurance is not mandated and should 
be, preferably through a state-regulated carrier.169 Similarly, the FDA has 
strict procedures to protect consumers from adulterated products—in order 
to simplify recalls and consumer notification, it requires responsible parties 
to report foods that may have contaminated other foods into a registry 
accessible by the FDA, in addition to consumer notification.170 These FDA 
procedures need to be emulated for cannabis in California. 
 
 
 166. CAL. CODE REGS. tit. 17, § 40297 (2019). 
 167. CAL. BUS & PROF. CODE § 26132(a)-(e) (2019); John Schroyer, Here’s How California Might 
Enforce Violations of Marijuana Business Rules, MARIJUANA BUSINESS DAILY (July 3, 2018), 
https://mjbizdaily.com/heres-how-california-might-enforce-violations-of-marijuana-business-rules/. 
 168. 21 U.S.C. § 350l (g) (2019). 
 169. There are four insurance companies that are approved state-regulated carriers offering liability 
insurance for the cannabis industry: Golden Bear Insurance Co., North River Insurance Co., U.S. Fire 
Insurance Co. and White Pine Insurance Co. Despite their ability to write surety bonds for cannabis 
businesses, there are still significant gaps in coverage, particularly in products liability. See Kevin Smith, 
Cannabis Companies Now Have Access to Property, Liability Insurance in California, CA.GOV (June 4, 
2018), https://cannabis.ca.gov/2018/06/05/cannabis-companies-now-have-access-to-property-liability-in 
surance-in-california/. 
 170. 21 U.S.C.A. § 350f(d)(1)(A-B) (West 2019); 21 U.S.C.A. § 350f(g-h) (West 2019). This includes 
posting notification at or near the register, providing location of the reportable food, and providing 
targeted recall info. 21 U.S.C.A § 350l (b) (West 2019). 
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3.4 DESIGN DEFECTS AND PROPOSED RESPONSE: SET NATIONAL 
STANDARD DOSAGE AT 10MG 
 
Design defect claims focus on the design itself. What is a “reasonable” 
design is still debatable due to a patchwork of state standards and the lack of 
a federal standard. The CDPH requires a clear delineation of a single 10mg 
serving, but products can still contain up to 100mg per package. This can 
potentially expose consumers to serious intoxication if they found it 
“reasonable” to eat the whole product. For example, a manufacturer that 
makes chocolate covered espresso beans with 100mg per package, each bean 
is 5mg—how unreasonable is it that the consumer would think to eat more 
than one bean, maybe three or four? If a consumer were injured while 
intoxicated, they could very likely bring a suit against a manufacturer 
alleging the “product was unreasonably dangerous” and it was reasonable to 
eat the entire package.171 The slow onset of cannabis oral consumption also 
implicates failure to warn issues. If cannabis was regulated like a food 
additive, the FDA could institute restrictions on labeling and serving size 
amounts, lessening liability for “inadequate” labeling or failure to warn 
issues. If cannabis was regulated as a dietary supplement, the FDA could 
institute conditions for recommended use under which the use will 
“reasonably be expected to be safe.”172  
Even if an edible comports with both the FDCA and California 
regulations, it would still be possible for a consumer to file a product liability 
suit for a design defect because what is considered “unreasonably 
dangerous” has not been properly determined by the FDA or by case 
precedent in California. Of particular note, the BCC and CDPH were 
recently asked to clarify the regulations around serving size because “if an 
edible cannabis product is labeled as containing 10 mg per serving, and 
testing shows that it contains 10.1 mg—which is within the BCC’s 10% 
variance—it would also meet CDPH product requirements.”173 However, the 
statutory requirement states that a standard dose must not exceed 10mg, 
creating a possible liability issue. The lack of a uniform national legal 
standard of 10mg (with little to no variance), and the current acknowledged 
BCC/CDPH variance, leaves manufacturers, distributors, and retailers at 
risk. Proper articulation of serving sizes need to be nationally espoused by 
the FDA. 
 
 
 171. Campbell & Singh, supra note 4, at 361. 
 172. U.S. FOOD & DRUG ADMINISTRATION, New Dietary Ingredients in Dietary Supplements – 
Background for Industry, (last visited Oct. 19, 2019), https://www.fda.gov/Food/DietarySupplement 
s/NewDietaryIngredientsNotificationProcess/ucm109764.htm. 
 173. Id. 
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3.5 INADEQUATE WARNINGS AND PROPOSED SOLUTION: ENSURING AN 
EDUCATED BUDTENDER AND CONSUMER 
 
Warning defect claims arise from a manufacturers failure to warn. 
Edible packaging and labeling requirements under the FDCA (potentially) 
and California regulations (currently) would certainly overlap in their goal 
of keeping products unattractive and unattainable to children. Thus, design 
defect issues can be lessened by strict packaging and labeling requirements. 
The National Label Education Act espouses that no state may establish any 
requirement for the labeling of food that is not identical to the federal 
requirements, which is complicated given that there is no federal standard 
for edibles. Edibles must already be child-resistant and comport with the 
Federal Poison Prevention Packaging Act of 1970. 
It is clear that manufacturers and retailers need to work together to 
lessen liability for failure to warn claims by instituting policies to ensure 
consumers are informed at the time of sale and prior to consumption. First 
and foremost, serving sizes need to be publicized through a national Public 
Service Announcement—10mg for the average adult. The Center for Disease 
Control (“CDC”) has a portal about “marijuana and public health,” but this 
portal does not address intoxication issues with edibles.174 The CDPH also 
has a “Let’s Talk about Cannabis” program, which is essentially a public 
relations experiment, which states that “by sharing science-based 
information, the CDPH is working to increase awareness about cannabis and 
its impacts on bodies, mind and health.”175 This portal is certainly a step in 
the right direction because consumers are eating food and drinks infused 
with cannabis and should be informed of their decisions. However, working 
with the FTC, cannabis companies need to be able to advertise similarly to 
what alcohol companies advertise on television, such as warning viewers to 
“Drink (Consume) Responsibly.” For example, Bacardi Rum advertisements 
advise consumers to “Enjoy Responsibly Together.”176 Until it becomes 
“common knowledge” that 10mg is the average adult serving size, this needs 
to be publicized as much as possible through all available, regulated avenues. 
 
 174. Marijuana and Public Health, CENTER FOR DISEASE CONTROL, https://www.cdc.gov/marijuana/ 
(last visited Oct. 19, 2019). 
 175. CDPH Warning for Safe Edible Consumption: “When you smoke or vape cannabis you may feel 
the effects quickly, but it can take between 30 minutes and two hours to feel the effects of edibles like 
cookies, sodas, and ice cream. Start with less than a single serving (less than 10 mg of THC), then wait 
before using more. It is important to know about the delayed effects of edibles because if you eat too 
much too quickly, you are at greater risk of poisoning. “Let’s Talk Cannabis: Responsible Use, 
CALIFORNIA DEPARTMENT OF PUBLIC HEALTH, https://www.cdph.ca.gov/Programs/DO/letstalkcannabis 
/Pages/responsibleuse.aspx (last visited May 3, 2019).  
176.  How Big Alcohol Abuses “Drink Responsibly” to Market its Products, ALCOHOL JUSTICE (May 
2012), https://alcoholjustice.org/images/stories/DrinkResponsiblyFinal.pdf. 
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As an additional precaution, manufacturers can contract with 
dispensaries to mandate “talking points” to coincide with the edible sale.177 
Dispensaries could place additional custom warning labels on edibles to 
further articulate expected effects, which the CDPH recommends but does 
not require. ‘Budtenders’ should be required to give additional instructions 
upon purchase about potential effects and articulate both the 10mg standard 
and first-time dosage recommendation. 178 Currently, the City of San 
Francisco requires all cannabis retailers to make a handout titled “Safe 
Consumption of Cannabis Products” available to customers, detailing 
possible effects of cannabis.179 Various dispensaries have met this 
requirement by simply posting a link on their website, however, is 
inadequate. This safe consumption handout needs to be visibly posted in 
stores, placed inside the opaque packaging, by checkout counters, in the 
display next to the products, and pointed out by the budtenders. Although 
there is already an individual daily purchase limit, a shared statewide system 
to track the daily limit sold to each consumer might also help mitigate the 
risk of dispensaries being “held liable for a potential ‘overdose’ or an 
improper sale.”180 
 
3.6 POSSIBLE IMPOSITION OF GRAM SHOP LAWS AND CALIFORNIA 
CIVIL CODE § 1714.45 
 
Notably, in California, liquor stores and licensed liquor establishments 
do not face liability for serving an individual, unless the individual is an 
obviously intoxicated minor.181 Yet, we currently hold cannabis product 
manufacturers liable for placing an unreasonably dangerous product on the 
market.182 Though not currently in place, California may choose to impose 
“gram shop” laws for cannabis, thus protecting dispensaries from liability 
for injuries suffered by customers.183 Under these statutes, “selling to a 
 
 177. Campbell & Singh, supra note 4, at 364. 
 178. Id. 
 179. Safe Consumption of Cannabis Products, SAN FRANCISCO OFFICE OF CANNABIS (Jan. 4, 2018), 
https://www.sfdph.org/dph/files/csl/SAFE-CONSUMPTION-OF-CANNABIS-PRODUCTS-FACT-SH 
EET.pdf. 
 180. Persons 21 and older, can buy and possess up to 28.5 grams of cannabis, up to 8 grams of 
cannabis concentrate and up to 6 live plants. Alex Wigglesworth, Legal Weed in California: A 
Consumer’s Guide, LOS ANGELES TIMES (April 20, 2018), https://www.latimes.com/politics/la-pol-ca-
cannabis-consumer-guide-20180420-htmlstory.html; see also Burton & May, supra note 15, 10. 
181.  CAL. BUS & PROF. CODE § 25602.1 (2019).  
182.  Burton & May, supra note 15, at 10, 26. 
 183. Campbell & Singh, supra note 4, at 379; Ken Stratton, “Gram Shop” Laws – What They Are 
and Why We Need Them in California, ROGOWAY LAW GROUP (Jan. 9, 2019), https://www.rogo 
waylaw.com/gram-shop-laws-cannabis-california/. 
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clearly-intoxicated person is considered negligent,” but dispensaries would 
otherwise be protected from “civil liability flowing from the bad behaviors 
of intoxicated customers.”184 Extending these laws to cover cannabis would 
not be difficult, as shown by the recent extension of immunity to alcohol-
infused energy drinks.185 However, causation for intoxication is difficult to 
prove, given that THC remains in a person’s system long after their “high” 
is over.186 
Additionally, the cannabis industry is not currently privy to the 
immunity provided by California Civil Code section 1714.45, which shields 
manufacturers and sellers from product liability if both of the following 
apply: 
“(1) The product is inherently unsafe and the product is known to be 
unsafe by the ordinary consumer who consumes the product with the 
ordinary knowledge common to the community;” and (2) the product “is a 
common consumer product intended for personal consumption, such as 
sugar, castor oil, alcohol, and butter.”187 
“This statute has never been applied to cannabis, [so] it is unclear 
whether cannabis qualifies as either an ‘inherently unsafe’ product or a 
“common consumer product.”188 
Additionally, if sued under current federal law, retailers’ defense could 
be that the CSA does not create a “substantive private right to invoke.”189 
However, cannabis “companies can further insulate themselves if they are 
able to prove to a jury that they went beyond adherence to just state laws.”190 
Given the lack of precedent, product liability issues will surely be one of the 
most challenging compliance issues for cannabis companies, because 
California’s strict liability products standards subject all those integral to the 
manufacturing and distribution process to liability. Addressing product 
liability issues for edibles, in view of FDCA complaints, is particularly 
relevant given that this burgeoning area of law is still in its infancy. Because 
of the current state by state legal quagmire, edible manufacturers should 
continue to provide information about the continued federal illegality of 
cannabis and the lack of FDA and DEA approval on all cannabis products.191 
 
 
 
 184. Campbell & Singh, supra note 4, at 379; Stratton, supra note 181.  
 185. Stratton, supra note 184.  
 186. Campbell & Singh, supra note 4, at 379. 
 187. CAL. CIVIL CODE § 1714.45 (2019). 
 188. Stratton, supra note 184.  
 189. Id. at 381. 
 190. Id. at 386. 
 191. Campbell & Singh, supra note 4, at 383. 
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CONCLUSION 
 
In short, the rise in consumption of cannabis edible products poses 
unique challenges for cannabis companies. Public safety relations for edible 
consumption is going to be best served by continued consumer education. 
Start low and slow. Complicated product liability issues are certainly 
foreseeable for manufactured cannabis edibles. Manufacturing defects can 
result from tainted flowers, falsified testing results, and not using clean, 
quality products. Manufacturing defects may occur, however, and defective 
products can get on the market. Nevertheless, zealous recall processes and 
consumer notification procedures can likely lessen this impact of consumer 
harm. Design defects will likely arise due to a lack of a community standard 
as to what is truly a “reasonable design.” Consumer education is key to 
having an informed consumer and to lessen over consumption—10mg is the 
standard dosage. Failure to warn issues will also likely arise due to an 
edible’s slow onset, and often deceiving appearance and taste resembling 
candy. Failure to warn issues could be lessened by mandating budtender 
talking points at sale, such as drawing attention to the dosages and handing 
out warnings about effects of consumption. Ultimately, cannabis needs to be 
de-scheduled from the CSA, and properly funded federal studies on the effect 
of cannabis must be conducted, particularly concerning edible products, just 
as California is currently doing.192 The FDA states that they remain 
committed to “exploring an appropriate, efficient and predictable regulatory 
framework” for cannabis-derived products, so the future is optimistic.193 
Frankly, in order to set proper federal regulations of edible products, an act 
of Congress may be needed. As this Note has articulated, it is possible to 
properly regulate edible cannabis products as either a food additive or a 
dietary supplement to ensure safe, enjoyable consumption and lessen 
exposure to product liability issues. Adult-use cannabis is here to stay—your 
move, Congress. 
 
 
 192. The bureau contracted with the California Cannabis Research Program (as known as the Center 
for Medicinal Cannabis Research) pursuant to § 11362.9 of the H&S Code to develop a study that 
identifies the impact that cannabis has on motor skills. CAL. BUS & PROF. CODE § 26190.5 (2019). The 
Medical Cannabis Research Act of 2019 was recently introduced to the House of Representatives, which 
would force the DEA to issue three registrations “to manufacture cannabis for legitimate research 
purposes within a year.” Despite the fact that cannabis will remains a Schedule I drug, this bill is a step 
in the right direction. Currently, federal researchers obtain their medical cannabis from one subpar source 
and if this bill passed at least the studied product would potentially be of better quality, improving the 
studies themselves. John A. Gilbert & Larry K. Houck, Medical Cannabis Research Act Stirs DEA 
Marijuana Registration Pot, FDA Law Blog (Apr. 10, 2019), http://www.fdalawblog.net/2019/04/medic 
al-cannabis-research-act-stirs-dea-marijuana-registration-pot/. 
 193. Gottlieb, supra note 43. 
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